SCHEMBL3049043

SCHEMBL3049043

COc1cc2c(cc1OCc1ccccc1)CCCNC2=O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.50
GPR84 Q9NQS5 1/20 0.49
PDE4B Q07343 2/20 0.46
PDE4A P27815 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
CTSV O60911 2/20 0.46
CTSL P07711 2/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR1A P08908 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR7 P34969 1/20 0.45
HTR2B P41595 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3055592 0.93 CHRNA7 (0.52) CHRNA7GPR84PDE4BPDE4APDE4C
SCHEMBL5762667 0.84 CHRNA7 (0.55) CHRNA7PDE4BPDE4APDE4CPDE4D
SCHEMBL9620526 0.83 MAOA (0.57) CHRNA7GPR84PDE4BMEN1KMT2A
SCHEMBL11147426 0.83 MAOA (0.61) CHRNA7GPR84PDE4BHTR1AHTR2A
SCHEMBL5713217 0.83 MAOA (0.61) CHRNA7GPR84PDE4BHTR1AHTR2A
SCHEMBL9621181 0.83 MAOA (0.57) CHRNA7GPR84PDE4BMEN1KMT2A
SCHEMBL4814842 0.80 CHRNA7 (0.56) CHRNA7GPR84PDE4BCTSVCTSL
SCHEMBL3970008 0.80 CHRNA7 (0.56) CHRNA7GPR84PDE4BCTSVCTSL
SCHEMBL25897227 0.80 PARP11 (0.52) HTR2AHTR2CMAOAMAOB
SCHEMBL13178658 0.80 PDE3B (0.43) GPR84PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
EP-2155192-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS Sterix Limited (GB) 2010-02-24 EP disclosed
WO-2008117061-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS STERIX LIMITED (GB) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC CHRNA7 4760/4885GPR84 2185/4885PDE4B 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.